Latest Articles

Publication Date
External ureteral involvement as a result of ovarian cancer initially suspected as endometriosis leading to the diagnosis of squamous cell carcinoma.

Ovarian squamous cell carcinoma [SCC] is a rare and aggressive malignancy that can mimic benign gynecological disorders, often leading to diagnostic delays and suboptimal management. Ureteral obstruction and subsequent hydroureteronephrosis …

Published: Feb. 15, 2025, midnight
Ultrasound in endometrial cancer:evaluating the impact of pre-surgicalstaging - Frontiers

Ultrasound in endometrial cancer:evaluating the impact of pre-surgicalstaging Frontiers

Published: Feb. 14, 2025, 7:44 a.m.
Calls for Labor to ensure Australia isn’t ‘caught up’ in America’s ‘damaging’ tariffs - Townsville Bulletin

Calls for Labor to ensure Australia isn’t ‘caught up’ in America’s ‘damaging’ tariffs Townsville Bulletin

Published: Feb. 13, 2025, 10:13 p.m.
A case of deep endometriosis with cyst formation as a differential diagnosis of rectal duplication cyst in the presacral space.

Cysts occurring in the presacral space may become malignant and therefore require surgical removal. A wide variety of cystic lesions can occur in the presacral space, such as tailgut cysts, …

Published: Feb. 12, 2025, midnight
Endometriosis imaging agent impresses at clinical trials - Health Imaging

Endometriosis imaging agent impresses at clinical trials Health Imaging

Published: Feb. 10, 2025, 12:39 p.m.
Serac Healthcare secures FDA backing for next stage endometriosis diagnosis imaging trial - substack.com

Serac Healthcare secures FDA backing for next stage endometriosis diagnosis imaging trial substack.com

Published: Feb. 9, 2025, 10:54 a.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Imaging Technology News

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Imaging Technology News

Published: Feb. 5, 2025, 3:56 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - StreetInsider.com

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent StreetInsider.com

Published: Feb. 5, 2025, 1:51 p.m.
Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent - Yahoo Finance

Serac Healthcare Announces Successful FDA End of Phase II Meeting for Endometriosis Imaging Agent Yahoo Finance

Published: Feb. 5, 2025, 1:51 p.m.
Serac Healthcare Advances Non-Invasive Endometriosis Imaging Test Following FDA Meeting - Femtech Insider

Serac Healthcare Advances Non-Invasive Endometriosis Imaging Test Following FDA Meeting Femtech Insider

Published: Feb. 5, 2025, 12:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!